Rhodiola rosea
Dietary supplement
What it is
Rhodiola rosea is an arctic root whose standardized extract appears to moderate the fatigue response to sustained stress. In trials of people under real load — physicians on night shifts, adults with stress-related fatigue, students in exam periods — supplemented groups reported better perceived energy and attention than placebo groups.
The evidence base is real but modest: the trials are small, mostly short, and concentrated on demanding stretches rather than everyday life. That shapes our guidance — rhodiola earns a B for stress support during high-load periods, and only a C for focus and endurance, where results are thinner and mixed. The table below carries the specifics.
Evidence by goal
-
Less fatigue-related decline on cognitive tasks during night-shift work, and lower burnout-scale scores with better attention over 28 days at 576 mg per day.
-
Better self-rated wellbeing and physical work capacity during an exam period in one 40-person trial; the cognitive-test results were mixed.
-
An acute 3 mg/kg dose modestly shortened a 6-mile cycling time-trial and lowered perceived exertion in one 18-person crossover study — small and acute, a secondary use at most.
Forms compared
- Standardized extract. The trials used extracts standardized to about 3% rosavins and 1% salidroside. Match those numbers on the label — unstandardized root powder does not map to the evidence.
Dose and timing
200–600 mg of standardized extract in the morning, before food. Avoid late-day doses — it is mildly stimulating for some people and can delay sleep. The trial pattern favors use during demanding stretches over indefinite daily dosing.
Evidence-backed range: 200–600 mg per day.
Cautions and interactions
- Mildly stimulating for some — taken late in the day it can delay sleep.
- Rhodiola may influence serotonergic signaling. If you take an SSRI or related medication, combine only with your prescriber informed — the combination data are thin, and we flag the pairing rather than assume safety.
- It can stack with prescription stimulant medication — jitteriness and disturbed sleep are the likely cost. Combine carefully, if at all.
- No safety data exist for pregnancy or nursing. Skip it there.
From our interaction tables
- avoid Pregnancy. No safety data exist for rhodiola in pregnancy. We exclude it.
- caution SSRIs (class). Rhodiola may influence serotonergic signaling, and combination data with SSRIs are thin. If you combine them, do it with your prescriber informed.
- caution Prescription stimulant medication. Rhodiola is mildly activating and can stack with prescription stimulants — jitteriness and disturbed sleep are the likely cost. Combine carefully, if at all.
Who should skip this
- People who are pregnant or nursing.
- People on an SSRI or prescription stimulant medication, unless their prescriber approves the combination.
- People whose sleep is already fragile — the mild stimulation can work against them.
Questions we actually get
What should the label say?
Standardization to about 3% rosavins and 1% salidroside — that is what the trials used. Without those numbers you are buying an unknown.
Should I take it every day or only when things are hard?
The trial evidence comes from demanding stretches — night shifts, exam periods, stress-related fatigue. Using it during those windows matches the data better than indefinite daily use.
When in the day should I take it?
Morning, before food. Late doses can delay sleep in people who feel its mild stimulation.
Does it work for exercise?
One small crossover study found an acute dose modestly improved a cycling time-trial. We grade endurance C — interesting, not established.
Sources
- Darbinyan V, Kteyan A, Panossian A, et al., Phytomedicine, 2000 — crossover RCT in physicians on night duty
- Olsson EM, von Schéele B, Panossian AG, Planta Medica, 2009 — RCT of standardized extract in adults with stress-related fatigue
- Spasov AA, Wikman GK, Mandrikov VB, et al., Phytomedicine, 2000 — RCT in students during an examination period
- Noreen EE, Buckley JG, Lewis SL, et al., Journal of Strength and Conditioning Research, 2013 — RCT of acute rhodiola before a 6-mile cycling time-trial
Last reviewed: pending review